These effects, concurrently with the reduction of oxidative stress, lowering of TGFβ-1, and stimulation of Nrf2, led to the blocking of pathogenic pathways involved in the development of liver fibrosis, chronic inflammation, and collagen deposition. Here, TGFB1 is linked to Hepatic fibrosis.